Please Wait
Applying Filters...
USFDA APPLICATION NUMBER - 204760 / DOSAGE - TABLET;ORAL - EQ 12.5MG BASE
| Active Ingredient/Active Moiety | ||
| Ingredient Name | Basis of Strength | Strength |
|---|---|---|
| NALOXEGOL OXALATE(UNII: 65I14TNM33) (NALOXEGOL - UNII:44T7335BKE) | NALOXEGOL | 25mg | 12.5mg |
Inactive Ingredients
| Ingredient Name | Avera McKennan Hospital | AstraZeneca Pharmaceuticals LP |
|---|---|---|
| CELLULOSE, MICROCRYSTALLINE(OP1R32D61U) | ||
| CROSCARMELLOSE SODIUM(M28OL1HH48) | ||
| FERRIC OXIDE RED(1K09F3G675) | ||
| FERROSOFERRIC OXIDE(XM0M87F357) | ||
| HYPROMELLOSE, UNSPECIFIED(3NXW29V3WO) | ||
| HYPROMELLOSES(3NXW29V3WO) | ||
| MAGNESIUM STEARATE(70097M6I30) | ||
| MANNITOL(3OWL53L36A) | ||
| MICROCRYSTALLINE CELLULOSE(OP1R32D61U) | ||
| POLYETHYLENE GLYCOL 400(B697894SGQ) | ||
| PROPYL GALLATE(8D4SNN7V92) | ||
| TITANIUM DIOXIDE(15FIX9V2JP) | ||
| WATER(059QF0KO0R) |
